Literature DB >> 8139041

A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1.

C Van Lint1, J Ghysdael, P Paras, A Burny, E Verdin.   

Abstract

Analysis of the chromatin organization of the integrated human immunodeficiency virus type 1 (HIV-1) genome has previously revealed a major constitutive DNase I-hypersensitive site associated with the pol gene (E. Verdin, J. Virol. 65:6790-6799, 1991). In the present report, high-resolution mapping of this site with DNase I and micrococcal nuclease identified a nucleosome-free region centered around nucleotides (nt) 4490 to 4766. A 500-bp fragment encompassing this hypersensitive site (nt 4481 to 4982) exhibited transcription-enhancing activity (two- to threefold) when it was cloned in its natural position with respect to the HIV-1 promoter after transient transfection in U937 and CEM cells. Using in vitro footprinting and gel shift assays, we have identified four distinct binding sites for nuclear proteins within this positive regulatory element. Site B (nt 4519 to 4545) specifically bound four distinct nuclear protein complexes: a ubiquitous factor, a T-cell-specific factor, a B-cell-specific factor, and the monocyte/macrophage- and B-cell-specific transcription factor PU.1/Spi-1. In most HIV-1 isolates in which this PU box was not conserved, it was replaced by a binding site for the related factor Ets1. Factors binding to site C (nt 4681 to 4701) had a DNA-binding specificity similar to that of factors binding to site B, except for PU.1/Spi-1. A GC box containing a binding site for Sp1 was identified (nt 4623 to 4631). Site D (nt 4816 to 4851) specifically bound a ubiquitously expressed factor. These results identify a transcriptional regulatory element associated with a nuclease-hypersensitive site in the pol gene of HIV-1 and suggest that its activity may be controlled by a complex interplay of cis-regulatory elements.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139041      PMCID: PMC236741     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  87 in total

Review 1.  Regulation of human immunodeficiency virus replication.

Authors:  B R Cullen
Journal:  Annu Rev Microbiol       Date:  1991       Impact factor: 15.500

2.  The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites.

Authors:  C Van Lint; A Burny; E Verdin
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1.

Authors:  H Soudeyns; R Geleziunas; G Shyamala; J Hiscott; M A Wainberg
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

4.  Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis.

Authors:  D L Galson; J O Hensold; T R Bishop; M Schalling; A D D'Andrea; C Jones; P E Auron; D E Housman
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

5.  NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.

Authors:  V M Tesmer; A Rajadhyaksha; J Babin; M Bina
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.

Authors:  B Nelsen; G Tian; B Erman; J Gregoire; R Maki; B Graves; R Sen
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

7.  The PU.1/Spi-1 proto-oncogene is a transcriptional regulator of a lentivirus promoter.

Authors:  M Carvalho; D Derse
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins.

Authors:  T A Brown; S L McKnight
Journal:  Genes Dev       Date:  1992-12       Impact factor: 11.361

9.  Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.

Authors:  C Balotta; P Lusso; R Crowley; R C Gallo; G Franchini
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation.

Authors:  E Verdin; P Paras; C Van Lint
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  31 in total

1.  Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity.

Authors:  C Van Lint; C A Amella; S Emiliani; M John; T Jie; E Verdin
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency.

Authors:  S Emiliani; C Van Lint; W Fischle; P Paras; M Ott; J Brady; E Verdin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 4.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

5.  A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.

Authors:  Sriram Vijayraghavan; Boris Kantor
Journal:  J Vis Exp       Date:  2017-12-12       Impact factor: 1.355

Review 6.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

Review 7.  Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences.

Authors:  Nobubelo K Ngandu; Konrad Scheffler; Penny Moore; Zenda Woodman; Darren Martin; Cathal Seoighe
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

8.  The murine AIDS defective provirus acts as an insertional mutagen in its infected target B cells.

Authors:  M Huang; M Takac; C A Kozak; P Jolicoeur
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.

Authors:  Vincent Quivy; Emmanuelle Adam; Yves Collette; Dominique Demonte; Alain Chariot; Caroline Vanhulle; Ben Berkhout; Rémy Castellano; Yvan de Launoit; Arsène Burny; Jacques Piette; Vincent Bours; Carine Van Lint
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Anti-leukemia activity of MS-275 histone deacetylase inhibitor implicates 4-1BBL/4-1BB immunomodulatory functions.

Authors:  Bérengère Vire; Stéphane de Walque; Audrey Restouin; Daniel Olive; Carine Van Lint; Yves Collette
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.